Exeliom Biosciences is a clinical-stage biopharmaceutical company headquartered in France that develops novel therapeutic approaches harnessing microbiome-host interactions.
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Exeliom Biosciences →Already a subscriber? Sign in
Xcout Intel tracks Exeliom Biosciences continuously — this profile deepens as new filings, funding, people and hiring data arrive.